3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
11
Prostatic Neoplasms
9
Breast Neoplasms
9
Leukemia, Myeloid, Acute
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Neuroblastoma
6
Myelodysplastic Syndromes
6
Multiple Myeloma
6
Melanoma
6
Lymphoma
6
Glioblastoma
6
Ovarian Neoplasms
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Glioma
4
Osteosarcoma
3
Neoplasm Metastasis
3
Lymphoma, Non-Hodgkin
3
Kidney Neoplasms
3
Fallopian Tube Neoplasms
3
Breast Neoplasms, Male
3
Neoplasms, Plasma Cell
2
Neoplasms
2
Medulloblastoma
2
Hodgkin Disease
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Interventions
Temozolomide
30
Radiotherapy
21
Etoposide
9
Carboplatin
9
Bevacizumab
9
Cyclophosphamide
8
Vincristine
7
Radiation
7
Filgrastim
7
Cisplatin
7
Magnetic Resonance Spectroscopy
6
Irinotecan
5
Ifosfamide
5
Granulocyte Colony-Stimulating Factor
5
etoposide phosphate
4
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Lomustine
4
Everolimus
4
selpercatinib
3
larotrectinib
3
Thalidomide
3
Paclitaxel
3
Nuclear Medicine Department, Hospital
3
Methotrexate
3
Erlotinib Hydrochloride
3
Chemotherapy, Adjuvant
3
Celecoxib
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Central Nervous System Neoplasms
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
Clear all
No trials found.